Determination of the Feasibility of Tumoural Somatic Mutations Detection in Blood of Patients With Ovarian Cancer
NCT03881683
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer
Interventions
DIAGNOSTIC_TEST:
HRD and BRCA mutations
Sponsor
Institut de Cancérologie de Lorraine